AKTX

Q: What is the price of Akari Therapeutics (AKTX) today?

The price of Akari Therapeutics (AKTX) today is R$ 4,66, with a variation of -77.37% compared to the last year. The price of Akari Therapeutics (AKTX) started the year trading around R$ 6,61 and today it is at R$ 4,66. Follow the real-time price chart, the historical price of Akari Therapeutics (AKTX), and stock data from Ibovespa and international markets.

Q: When does Akari Therapeutics (AKTX) pay dividends?

Akari Therapeutics (AKTX) did not distribute dividends in the last year.

Q: Akari Therapeutics (AKTX) is it worth it?

Currently, Akari Therapeutics (AKTX) is priced at R$ 4,66, with a P/E of -2,33%, representing a deviation of -13,20% from its historical average P/E. In the last year, the stock showed a variation of -77.37% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was -77,37%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy shares of Akari Therapeutics (AKTX)?

Investing in shares of Akari Therapeutics (AKTX) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 shares of Akari Therapeutics (AKTX) yield today?

The yield of Akari Therapeutics (AKTX) was -23,21% in the last month, -77,37% in the last year and -97,44% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 shares of Akari Therapeutics (AKTX) today, the total investment would be based on the current price of R$ 4,66.If past performance were to repeat, the return on your investment would be:In 1 year: R$ 105,48In 5 years: R$ 11,93In 10 years: 0,79It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Akari Therapeutics PLC

Price

US$ 0,86

variation (12m)

-77,37%

p/l

-2,33

p/vp

1,12

DIVIDEND YIELD

0,00%

quote AKTX

BVMF

AKTX

If you had invested

year ago

6 months

1 year

5 years

10 years

today you would have

today you would have:

*The figure considers the reinvestment of dividends.

profitability of AKTX

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

-23,21%

3 months

-33,85%

1 year

-77,37%

2 years

-75,94%

5 years

-97,44%

10 years

-99,83%

real profitability

profitability minus inflation.

1 month

-23,21%

3 months

-34,18%

1 year

-78,50%

2 years

-78,07%

5 years

-98,13%

10 years

-99,90%

Indicators AKTX

check out the fundamentals of Akari Therapeutics shares

P/L

-2,33

Sector: -1,52 Industry: -3,80

P/SALES (PSR)

Sector: 1,99 Industry: 2,90

P/VP

1,12

Sector: 2,16 Industry: 1,76

DIVIDEND YIELD (DY)

0,00%

Sector: - Industry: -

ROA

-24,12%

Sector: -26,53% Industry: -56,94%

ROE

-47,95%

Sector: -31,21% Industry: -45,34%

ROIC

-23,97%

Sector: -404,40% Industry: -420,46%

Net Margin

0,00%

Sector: -26,56% Industry: -32,35%

GROSS MARGIN

0,00%

Sector: 44,49% Industry: 44,86%

OPERATING MARGIN

0,00%

Sector: -23,10% Industry: -30,21%

P/EBITDA

-2,38

Sector: 0,07 Industry: -2,60

P/EBIT

-2,38

Sector: -1,37 Industry: -3,22

P/ASSETS

0,56

Sector: 1,23 Industry: 1,32

VPA

0,83

Sector: 3,66 Industry: 1,68

LPA

-0,40

Sector: -0,80 Industry: -1,22

EQUITY / ASSETS

0,50

Sector: 0,45 Industry: 0,48

CAGR REVENUES 5 YEARS

0,00%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

-6,39%

Sector: - Industry: -

AKTX indicators history

DRAG THE FRAME TO SEE MORE DATA

comparator of Stocks

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	Net Margin
LLY	45,25	34,03	75,21%	0,81%	US$ 624,41 B	25,91%
ISRG	65,56	9,52	14,52%	0,00%	US$ 170,94 B	28,51%
TMO	28,71	3,73	13,01%	0,33%	US$ 189,00 B	15,24%
MDT	25,50	0,00	0,00%	3,03%	US$ 118,85 B	13,63%
SNY	11,17	1,55	13,90%	4,31%	US$ 125,86 B	14,83%
CVS	19,92	1,16	5,84%	3,73%	US$ 90,27 B	1,17%
GSK	17,94	4,15	23,12%	4,04%	US$ 80,77 B	10,87%
ABT	15,66	4,31	27,50%	1,81%	US$ 218,97 B	32,43%
NVS	18,12	5,88	32,47%	3,05%	US$ 247,36 B	24,74%
TMDX	56,86	12,81	22,53%	0,00%	US$ 4,07 B	13,49%
HCA	16,35	-78,84	-482,31%	0,68%	US$ 97,60 B	8,21%
BSX	62,73	6,94	11,06%	0,00%	US$ 157,13 B	13,54%
INMD	5,22	1,48	28,44%	0,00%	US$ 933,03 M	44,50%
DHR	44,49	2,90	6,52%	0,56%	US$ 151,86 B	14,21%
IDXX	52,40	35,40	67,57%	0,00%	US$ 51,64 B	24,41%
FMS	20,59	0,91	4,42%	3,07%	US$ 15,03 B	3,41%
HUM	23,00	1,98	8,61%	1,18%	US$ 36,24 B	1,28%
PHG	127,59	2,23	1,75%	3,13%	US$ 26,81 B	1,07%
DXCM	56,42	12,53	22,21%	0,00%	US$ 32,25 B	13,29%

comparison of AKTX with indexes

If you had invested (change) 2 years a year ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

dividend history AKTX dividend history

Current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY Akari Therapeutics

Akari Therapeutics PLC

Average user rating I10

4.0 (0 people)

Estados Unidos

21 years

Foundation: 2004

2012

Year of debut on the stock exchange - 13 years

10

Employees

The Company Akari Therapeutics PLC (Estados Unidos), is listed on Nasdaq with a market value of $ 28,57 Milhões, having a net worth of $ 25,61 Milhões.

With a total of 10 employees, the company is listed in the sector of Saúde and categorized in industry of Produtos Farmacêuticos.

In the last 12 months the Company had a revenue of $ -, which generated a loss in the amount of $ -12,28 Milhões.

As for its main indicators, the Company has a P/E ratio of -2,33, a P/B ratio of 1,12 and in the last 12 months the Company did not pay dividends.

The Company is traded through the ticker AKTX.

Market value

US$ 28,57 Milhões

Net worth

US$ 25,61 Milhões

US$ 25.610.000,00

Assets

US$ 50,91 Milhões

US$ 50.910.000,00

Total Number of Shares

31,00 Milhões

31.000.000

Average Daily Trading Volume

US$ 31,23 Thousand

US$ 31.231,74

Sector

Saúde

Industry

Produtos Farmacêuticos

AKTX

AKTX revenue and profits

AKTX results

DRAG THE FRAME TO SEE MORE DATA

AKTX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

LBPSW - 4D pharma

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 71,55 30,23% (12M)

P/L

19,92

3,73%

ROE

5,84%

P/VP

1,16

CI - Cigna

US$ 300,32 --13,19% (12M)

P/L

16,13

1,91%

ROE

12,41%

P/VP

2,00

CNC - Centene

US$ 28,66 --63,26% (12M)

P/L

7,07

0,00%

ROE

7,47%

P/VP

0,53

HUM - Humana

US$ 298,87 --14,32% (12M)

P/L

23,00

1,18%

ROE

8,61%

P/VP

1,98

SNY - Sanofi

US$ 50,30 --6,73% (12M)

P/L

11,17

4,31%

ROE

13,90%

P/VP

1,55

HCA - HCA Healthcare

US$ 401,96 4,05% (12M)

P/L

16,35

0,68%

ROE

-482,31%

P/VP

-78,84

LLY - Eli Lilly

US$ 736,03 --22,19% (12M)

P/L

45,25

0,81%

ROE

75,21%

P/VP

34,03

LBPSW - 4D pharma

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 71,55 30,23% (12 M)

P/L

19,92

3,73%

ROE

5,84%

P/VP

1,16

CI - Cigna

US$ 300,32 --13,19% (12 M)

P/L

16,13

1,91%

ROE

12,41%

P/VP

2,00

CNC - Centene

US$ 28,66 --63,26% (12 M)

P/L

7,07

0,00%

ROE

7,47%

P/VP

0,53

HUM - Humana

US$ 298,87 --14,32% (12 M)

P/L

23,00

1,18%

ROE

8,61%

P/VP

1,98

SNY - Sanofi

US$ 50,30 --6,73% (12 M)

P/L

11,17

4,31%

ROE

13,90%

P/VP

1,55

HCA - HCA Healthcare

US$ 401,96 4,05% (12 M)

P/L

16,35

0,68%

ROE

-482,31%

P/VP

-78,84

LLY - Eli Lilly

US$ 736,03 --22,19% (12 M)

P/L

45,25

0,81%

ROE

75,21%

P/VP

34,03

Common Questions

What is the price of Akari Therapeutics (AKTX) today?

The price of Akari Therapeutics (AKTX) today is R$ 4,66, with a variation of -77.37% compared to the last year. The price of Akari Therapeutics (AKTX) started the year trading around R$ 6,61 and today it is at R$ 4,66. Follow the real-time price chart, the historical price of Akari Therapeutics (AKTX), and stock data from Ibovespa and international markets.

When does Akari Therapeutics (AKTX) pay dividends?

Akari Therapeutics (AKTX) did not distribute dividends in the last year.

Akari Therapeutics (AKTX) is it worth it?

Currently, Akari Therapeutics (AKTX) is priced at R$ 4,66, with a P/E of -2,33%, representing a deviation of -13,20% from its historical average P/E. In the last year, the stock showed a variation of -77.37% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was -77,37%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy shares of Akari Therapeutics (AKTX)?

Investing in shares of Akari Therapeutics (AKTX) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 shares of Akari Therapeutics (AKTX) yield today?

The yield of Akari Therapeutics (AKTX) was -23,21% in the last month, -77,37% in the last year and -97,44% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.

If you wanted to buy 100 shares of Akari Therapeutics (AKTX) today, the total investment would be based on the current price of R$ 4,66.

If past performance were to repeat, the return on your investment would be:

In 1 year: R$ 105,48
In 5 years: R$ 11,93
In 10 years: 0,79

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

AKTX

Akari Therapeutics PLC

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

profitability of AKTX

check out the fundamentals of Akari Therapeutics shares

P/L

P/SALES (PSR)

P/VP

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

Net Margin

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSETS

VPA

LPA

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

If you had invested (change) 2 years a year ago, today you would have

Current DY: 0,00%

5-year average DY: 0,00%

ABOUT THE COMPANY Akari Therapeutics

Akari Therapeutics PLC

Estados Unidos

21 years

2012

10

PROFIT X PRICE AKTX

AKTX results

AKTX cash flow

evolution of assets - AKTX

AKTX balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

Common Questions

Tudo que o investidor precisa em um só lugar

Pague 2, Leve 3

Anual

Valor total R$ 238,80